从3年纵向研究到COPD表型受试者的基线特征:FOOTPRINTS研究
James D Crapo1, Abhya Gupta2, David A Lynch3
1Department of Medicine, National Jewish Health, Denver, CO, USA. crapoj@njhealth.org.
Respiratory research
|November 18, 2023
概括
在前吸烟者的FOOTPRINTS研究发现,增加的炎症生物标志物与慢性阻塞性肺病 (COPD) 严重程度相关. 这些COPD患者的基线发现为未来的进展分析提供了背景.
科学领域:
- 肺部病理学 肺部病理学
- 生物标志物研究 生物标志物研究
- 慢性疾病流行病学 慢性疾病流行病学
背景情况:
- 脚印研究是对炎症和肺部破坏生物标志物的3年纵向评估,与COPD严重程度和进展有关.
- 它包括患有轻度至重度COPD的前吸烟者 (GOLD阶段1-3),患有COPD和α-1-抗素缺乏症 (A1ATD) 的前吸烟者,以及没有空气流限制的前吸烟者的对照组 (EwAL).
研究的目的:
- 呈现基线特征并从FOOTPRINTS研究队列中选择生物标志物.
- 为即将到来的分析建立背景,将生物标志物与COPD进展相关联.
主要方法:
- 数据收集包括人口统计,疾病特征,并发症,恶化,症状,肺功能,运动能力,可溶性生物标志物和CT成像.
- 用描述性统计来比较跨GOLD阶段,A1ATD和EwAL组的可溶性生物标志物.
主要成果:
- 来自456名前吸烟者的基线数据显示,症状增加,肺功能恶化,肺气和COPD严重程度更高的肺气 (GOLD 1-3).
- 患有A1ATD的受试者表现出与GOLD 2-3患者相似的肺功能和肺气特征.
- 与EWAL相比,GOLD 1-3和A1ATD组观察到炎症生物标志物 (白细胞计数,纤维素,hs-CRP,表面活性蛋白) 的增加.
结论:
- 在FOOTPRINTS研究中的基线生物标志物概况反映了COPD的严重程度和肺气.
- 这些发现为未来研究生物标志物与COPD进展之间的关系奠定了基础.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
COPD: Pathogenesis and Clinical Features
294
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
294
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K


